Valeant Pharma (NYSE: VRX) announced the addition of D. Robert Hale, Partner of ValueAct Capital, to its board of directors ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE